DaVita Inc

Market Summary

USD105.73+1.57

Market Closed

1.51%

DVA Alerts

Big jump in Earnings (Y/Y)

DVA Stock Price

View Fullscreen

DVA RSI Chart

DVA Alerts

Big jump in Earnings (Y/Y)

DVA Valuation

Market Cap

9.7B

Price/Earnings (Trailing)

15.86

Price/Sales (Trailing)

0.81

EV/EBITDA

9.78

Price/Free Cashflow

7.35

DVA Price/Sales (Trailing)

DVA Profitability

EBT Margin

7.36%

Return on Equity

45.97%

Return on Assets

2.76%

Free Cashflow Yield

13.61%

DVA Fundamentals

DVA Revenue

Revenue (TTM)

11.9B

Revenue Y/Y

5.85%

Revenue Q/Q

4.03%

DVA Earnings

Earnings (TTM)

609.0M

Earnings Y/Y

134.07%

Earnings Q/Q

38.02%

Price Action

Last 7 days

4.2%

Last 30 days

32.0%

Last 90 days

10.7%

Trailing 12 Months

41.3%

How does DVA drawdown profile look like?

DVA Financial Health

Current Ratio

1.25

Debt/Equity

8.45

Debt/Cashflow

0.23

DVA Investor Care

Shares Dilution (1Y)

1.38%

Diluted EPS (TTM)

6.58

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	11.7B	11.7B	11.9B	0
2022	11.6B	11.6B	11.6B	11.6B
2021	11.5B	11.6B	11.6B	11.6B
2020	11.5B	11.5B	11.5B	11.6B
2019	11.3B	11.3B	11.3B	11.4B
2018	11.1B	11.3B	11.4B	11.4B
2017	10.7B	10.8B	10.8B	10.9B
2016	10.2B	10.3B	10.5B	10.7B
2015	13.0B	13.3B	13.6B	10.0B
2014	12.0B	12.3B	12.5B	12.8B
2013	9.2B	10.1B	11.2B	11.8B
2012	7.1B	7.4B	7.6B	8.2B
2011	6.4B	6.5B	6.6B	6.8B
2010	6.2B	6.3B	6.4B	6.4B
2009	5.8B	5.9B	6.0B	6.1B
2008	5.4B	5.5B	5.6B	5.7B
2007	0	0	0	5.3B

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for DVA

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 15, 2023	nehra john m	acquired	-	-	529	-
Nov 15, 2023	desoer barbara j	acquired	-	-	529	-
Nov 15, 2023	berg charles	acquired	-	-	529	-
Nov 15, 2023	moore gregory j.	acquired	-	-	529	-
Nov 15, 2023	berry christopher michael	acquired	-	-	8,468	chief accounting officer
Nov 15, 2023	schechter adam h	acquired	-	-	529	-
Nov 15, 2023	hollar jason m.	acquired	-	-	529	-
Nov 15, 2023	yale phyllis r	acquired	-	-	529	-
Nov 15, 2023	schoppert wendy lee	acquired	-	-	454	-
Nov 15, 2023	arway pamela m	acquired	-	-	529	-

Which funds bought or sold DVA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	Raleigh Capital Management Inc.	new	-	10,020	10,020	-%
Dec 06, 2023	VisionPoint Advisory Group, LLC	unchanged	-	-207	3,309	-%
Dec 06, 2023	CITIGROUP INC	reduced	-14.36	-1,398,750	5,804,140	-%
Dec 01, 2023	B. Riley Wealth Advisors, Inc.	added	9.85	7,088	218,175	0.01%
Nov 30, 2023	Neo Ivy Capital Management	added	148	353,000	617,000	0.27%
Nov 27, 2023	BANQUE PICTET & CIE SA	sold off	-100	-2,163,220	-	-%
Nov 24, 2023	DEUTSCHE BANK AG\	added	25.2	3,753,820	24,841,100	0.02%
Nov 22, 2023	Graham Capital Management, L.P.	reduced	-37.00	-579,010	842,640	0.02%
Nov 22, 2023	Public Sector Pension Investment Board	added	12.38	30,060	554,513	-%
Nov 22, 2023	KBC Group NV	unchanged	-	-	4,804,000	0.02%

Latest Funds Activity

Are funds buying DVA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DVA

No. of Funds

Schedule 13G FIlings of DaVita Inc

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 09, 2023	vanguard group inc	6.84%	6,166,112	SC 13G/A
Feb 01, 2023	blackrock inc.	5.4%	4,822,086	SC 13G/A
Feb 14, 2022	berkshire hathaway inc	37.5%	36,095,570	SC 13D/A
Feb 09, 2022	vanguard group inc	7.34%	7,481,018	SC 13G/A
Feb 01, 2022	blackrock inc.	5.5%	5,654,952	SC 13G/A
Aug 04, 2021	berkshire hathaway inc	34.4%	36,095,570	SC 13D/A
Feb 16, 2021	berkshire hathaway inc	33.0%	36,095,570	SC 13D/A
Feb 10, 2021	vanguard group inc	7.69%	8,611,932	SC 13G/A
Jan 29, 2021	blackrock inc.	5.3%	5,939,662	SC 13G/A
Sep 21, 2020	berkshire hathaway inc	31.7%	36,095,570	SC 13D/A

Recent SEC filings of DaVita Inc

View All Filings

Date Filed	Form Type	Document
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading
Nov 17, 2023	4	Insider Trading

DVA Fair Value

Peers (Alternatives to DaVita Inc)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	507.1B	360.0B	1.94%	1.34%	23.38	1.41	14.24%	11.62%
CVS	95.3B	347.8B	5.35%	-27.64%	10.94	0.27	10.34%	159.11%
CI	91.1B	189.9B	-12.60%	-22.05%	13.64	1.92	5.24%	22.27%
HCA	68.3B	63.2B	8.96%	6.67%	11.95	1.08	5.62%	6.32%
CNC	39.7B	150.1B	3.44%	-15.03%	16.23	0.26	6.04%	21.35%
MID-CAP
DVA	9.7B	11.9B	32.01%	41.29%	15.86	0.81	2.36%	-10.41%
UHS	9.4B	14.0B	3.25%	4.87%	13.92	0.67	6.03%	-8.61%
CHE	8.6B	2.2B	-1.50%	10.15%	35.21	3.87	4.50%	-6.69%
ACHC	6.6B	2.9B	-3.11%	-12.16%	-359.29	2.29	13.16%	-106.47%
AMN	2.6B	4.1B	9.38%	-42.09%	9.26	0.63	-25.26%	-41.25%
SMALL-CAP
AMEH	1.6B	1.3B	13.24%	13.97%	34.75	1.17	27.06%	-27.04%
ADUS	1.4B	1.0B	6.69%	-15.76%	25.11	1.41	10.84%	30.19%
BKD	982.6M	3.0B	18.37%	74.00%	-7.96	0.33	6.98%	58.07%
BEAT	36.3M	-	2.22%	-73.51%	-2.51	-	-	-27.68%
AMS	15.3M	20.7M	7.02%	-13.27%	52.66	0.74	6.53%	-78.75%

DaVita Inc News

Latest updates

Nasdaq • 07 Dec 2023 • 04:36 pm • 17 hours ago

Centene (CNC), Mindoula to Address Mental Health Issues in Indiana

DirectorsTalk Interviews • 07 Dec 2023 • 03:37 pm • 18 hours ago

DaVita Inc. - Consensus 'hold' rating and -.3% Downside Potential

Nasdaq • 07 Dec 2023 • 03:20 pm • 19 hours ago

Here's Why You Should Retain OPKO Health (OPK) Stock for Now

Nasdaq • 07 Dec 2023 • 02:48 pm • 19 hours ago

Veeva Systems (VEEV) Beats on Q3 Earnings, Revises FY24 Outlook

Nasdaq • 07 Dec 2023 • 01:22 pm • 21 hours ago

Top 5 Mid-Cap Stocks Likely to Turn Large-Cap in 2024

Nasdaq • 06 Dec 2023 • 03:22 pm • 43 hours ago

3 Reasons to Retain AMN Healthcare (AMN) Stock in Your Portfolio

Nasdaq • 06 Dec 2023 • 02:24 pm • 44 hours ago

HealthEquity (HQY) Q3 Earnings Surpass Estimates, Margins Up

Nasdaq • 06 Dec 2023 • 12:34 pm • 45 hours ago

Accuray (ARAY) Launches VitalHold in Japan for Use With Radixact

Nasdaq • 05 Dec 2023 • 04:59 pm • 2 days ago

West Pharmaceutical's (WST) New Launch to Expand Portfolio

Nasdaq • 05 Dec 2023 • 10:22 am • 3 days ago

The Zacks Analyst Blog Highlights Cboe Global Markets, Gartner ...

InvestorsObserver • 04 Dec 2023 • 08:15 pm • 3 days ago

Should You Buy Davita Inc (DVA) Stock Monday?

Nasdaq • 04 Dec 2023 • 05:09 pm • 3 days ago

Here's Why You Should Invest in Haemonetics (HAE) Right Now

Forbes • 04 Dec 2023 • 02:33 pm • 3 days ago

A Charlie Munger Legacy - The Healthy Returns And Health Conundrum

Nasdaq • 04 Dec 2023 • 12:47 pm • 3 days ago

Top 5 High-Flying S&P 500 Stocks of November With More Upside

Nasdaq • 04 Dec 2023 • 12:27 pm • 3 days ago

Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now

Financials for DaVita Inc

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	4.0%	3,121	3,000	2,873	2,917	2,949	2,927	2,818	2,944	2,938	2,917	2,820	2,905	2,924	2,880	2,841	2,899	2,904	2,843	2,743	2,821	2,847
Costs and Expenses	1.2%	2,625	2,595	2,561	2,661	2,637	2,494	2,479	2,555	2,463	2,426	2,377	2,524	2,486	2,470	2,376	2,436	2,526	2,381	2,403	2,433	2,558
S&GA Expenses	3.5%	377	364	332	380	365	315	295	323	293	298	281	305	363	316	264	278	299	275	251	269	336
EBITDA Margin	-100.0%	-	0.14*	0.14*	0.15*	0.16*	0.17*	0.20*	0.21*	-	-	0.19*	0.19*	0.21*	0.21*	0.21*	0.20*	0.19*	0.18*	-	-	-
Income Taxes	41.0%	69.00	49.00	44.00	34.00	43.00	64.00	57.00	66.00	75.00	81.00	85.00	73.00	66.00	83.00	92.00	82.00	65.00	76.00	57.00	52.00	52.00
Earnings Before Taxes	28.1%	378	295	215	147	207	349	263	315	394	432	377	327	283	338	369	382	274	324	216	259	167
EBT Margin	-100.0%	-	0.07*	0.08*	0.08*	0.10*	0.11*	0.12*	0.13*	0.13*	0.12*	0.11*	0.11*	0.12*	0.12*	0.12*	0.10*	-	-	-	-	-
Net Income	38.0%	247	179	116	68.00	105	225	162	187	260	294	237	174	159	202	240	245	143	274	149	-149	-136
Net Income Margin	-100.0%	-	0.04*	0.04*	0.05*	0.06*	0.07*	0.08*	0.08*	0.08*	0.07*	0.07*	0.07*	0.07*	0.07*	0.08*	0.07*	-	-	-	-	-
Free Cashflow	-100.0%	-	326	315	150	567	46.00	199	340	409	530	9.00	260	324	514	205	461	-	-	-	-	-

Balance Sheet
(In Millions)

Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-0.2%	16,929	16,959	16,728	16,928	16,962	17,101	17,087	17,121	17,634	17,810	17,647	16,989	17,047	19,305	17,596	17,311	17,452	19,931	22,606	19,110	19,358
Current Assets	4.4%	3,135	3,002	3,040	3,155	3,202	3,264	3,129	3,168	3,840	3,979	3,867	3,149	3,430	5,780	4,024	3,690	3,999	6,391	9,225	8,424	8,930
Cash Equivalents	66.5%	545	327	317	244	368	356	421	555	1,139	1,206	1,061	502	817	3,036	1,488	1,209	1,357	3,682	561	415	540
Inventory	-0.6%	110	110	107	109	107	110	108	107	114	115	116	112	106	98.00	96.00	98.00	99.00	97.00	104	107	91.00
Net PPE	-1.9%	3,097	3,158	3,216	3,256	3,240	3,305	3,439	3,480	3,463	3,486	3,490	3,522	3,418	3,418	3,445	3,473	3,419	3,405	3,392	3,394	3,276
Goodwill	-0.3%	7,088	7,106	7,090	7,077	7,023	7,020	7,073	7,046	6,941	6,944	6,891	6,919	6,868	6,791	6,778	6,788	6,766	6,865	6,799	6,842	6,703
Liabilities	-1.6%	14,104	14,329	14,309	14,703	14,889	14,940	14,678	14,751	14,882	14,921	14,865	14,092	13,989	15,729	14,235	13,812	13,643	14,502	17,376	14,077	14,264
Current Liabilities	5.6%	2,538	2,403	2,565	2,620	2,537	2,311	2,420	2,399	2,363	2,386	2,315	2,476	2,499	4,275	2,221	2,372	2,207	5,707	8,231	4,891	4,855
Long Term Debt	-3.6%	8,285	8,598	8,418	8,693	8,867	9,065	8,687	8,729	8,771	8,798	8,830	7,917	7,867	7,895	8,442	7,978	8,014	5,378	5,787	8,173	8,441
Shareholder's Equity	17.9%	1,199	1,017	825	712	533	605	844	756	1,149	1,278	1,248	1,384	1,575	2,154	1,948	2,133	2,319	4,049	3,875	3,703	3,825
Retained Earnings	52.6%	715	469	290	174	847	741	516	354	1,644	1,384	1,090	853	2,032	1,873	1,671	1,432	3,349	3,206	2,932	2,743	3,951
Additional Paid-In Capital	-0.5%	553	556	590	607	609	578	595	540	525	523	603	597	694	719	720	749	907	989	990	995	1,056
Shares Outstanding	0.1%	91.00	91.00	91.00	90.00	90.00	94.00	96.00	97.00	105	106	109	110	121	122	125	126	151	166	166	166	167
Minority Interest	-4.5%	180	189	194	164	169	170	175	181	179	185	185	183	179	180	185	186	194	194	211	205	205

Cashflow (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	46.9%	661	450	463	344	711	188	322	530	567	680	154	485	483	651	360	681	641	610	141	389	458
Share Based Compensation	-9.1%	27.00	30.00	25.00	18.00	28.00	25.00	25.00	26.00	24.00	28.00	24.00	24.00	25.00	22.00	20.00	20.00	19.00	17.00	12.00	13.00	40.00
Cashflow From Investing	59.7%	-139	-347	-116	-213	-153	-144	-118	-336	-164	-159	-124	-338	-80.17	-244	-162	-138	-268	3,603	-200	-344	-237
Cashflow From Financing	-307.4%	-394	-96.84	-275	-230	-445	-103	-341	-774	-464	-381	537	-465	-2,621	1,143	97.00	-692	-2,693	-1,635	325	-202	-117
Buy Backs	-	-	-	-	-	185	381	236	656	322	244	316	433	704	-	322	547	1,764	73.00	-	-	356

DVA Income Statement

2023-09-30

CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Dialysis patient service revenues	$ 2,951,950	$ 2,846,494	$ 8,602,669	$ 8,372,874
Other revenues	169,382	102,200	391,731	320,132
Total revenues	3,121,332	2,948,694	8,994,400	8,693,006
Operating expenses:
Patient care costs	2,067,315	2,085,555	6,181,348	6,120,872
General and administrative	376,883	365,447	1,072,513	975,486
Depreciation and amortization	188,423	194,414	550,166	538,534
Equity investment income, net	(7,228)	(8,509)	(22,502)	(24,696)
Total operating expenses	2,625,393	2,636,907	7,781,525	7,610,196
Operating income	495,939	311,787	1,212,875	1,082,810
Debt expense	(98,080)	(99,680)	(302,361)	(256,057)
Debt Extinguishment And Modification Costs	0	0	7,962	0
Other loss, net	(19,650)	(4,898)	(14,525)	(7,968)
Income before income taxes	378,209	207,209	888,027	818,785
Income tax expense	68,848	42,515	161,621	163,757
Net income	309,361	164,694	726,406	655,028
Less: Net income attributable to noncontrolling interests	(62,729)	(59,328)	(185,536)	(162,731)
Net income attributable to DaVita Inc.	$ 246,632	$ 105,366	$ 540,870	$ 492,297
Earnings per share attributable to DaVita Inc.:
Basic net income	$ 2.70	$ 1.16	$ 5.95	$ 5.24
Diluted net income	$ 2.62	$ 1.13	$ 5.80	$ 5.07
Weighted average shares for earnings per share:
Basic shares	91,322,000	91,160,000	90,937,000	93,959,000
Diluted shares	94,041,000	93,263,000	93,317,000	97,153,000

DVA Balance Sheet

2023-09-30

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
ASSETS
Cash and Cash Equivalents, at Carrying Value	$ 449,458	$ 244,086
Restricted Cash and Cash Equivalents	95,667	94,903
Short-term investments	11,713	77,693
Accounts receivable, net	2,024,827	2,132,070
Inventories	109,620	109,122
Other receivables	352,965	413,976
Prepaid and other current assets	91,109	78,839
Income tax receivable	0	4,603
Total current assets	3,135,359	3,155,292
Property and equipment, net	3,097,483	3,256,397
Operating lease right-of-use assets	2,509,416	2,666,242
Intangible assets, net	185,403	182,687
Equity method and other investments	565,394	231,108
Long-term investments	45,320	44,329
Other long-term assets	302,142	315,587
Goodwill	7,088,223	7,076,610
Total assets	16,928,740	16,928,252
LIABILITIES AND EQUITY
Accounts payable	435,417	479,780
Other liabilities	808,000	802,469
Accrued compensation and benefits	770,184	692,654
Current portion of operating lease liabilities	393,440	395,401
Current portion of long-term debt	108,558	231,404
Income tax payable	22,331	18,039
Total current liabilities	2,537,930	2,619,747
Long-term operating lease liabilities	2,342,170	2,503,068
Long-term debt	8,285,146	8,692,617
Other long-term liabilities	184,944	105,233
Deferred income taxes	753,871	782,787
Total liabilities	14,104,061	14,703,452
Commitments and contingencies:
Noncontrolling interests subject to put provisions	1,445,403	1,348,908
Equity:
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	91	90
Additional paid-in capital	552,651	606,935
Retained earnings	715,357	174,487
Accumulated other comprehensive loss	(68,898)	(69,186)
Total DaVita Inc. shareholders' equity	1,199,201	712,326
Noncontrolling interests not subject to put provisions	180,075	163,566
Total equity	1,379,276	875,892
Total liabilities and equity	$ 16,928,740	$ 16,928,252

About DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

CEO	Mr. Javier J. Rodriguez
WEBSITE	www.davita.com
EMPLOYEES	65535

DaVita Inc Frequently Asked Questions

What is the ticker symbol for DaVita Inc? What does DVA stand for in stocks?

DVA is the stock ticker symbol of DaVita Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of DaVita Inc (DVA)?

As of Thu Dec 07 2023, market cap of DaVita Inc is 9.66 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DVA stock?

You can check DVA's fair value in chart. The fair value of DaVita Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of DaVita Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DVA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is DaVita Inc a good stock to buy?

The fair value guage provides a quick view whether DVA is over valued or under valued. Whether DaVita Inc is cheap or expensive depends on the assumptions which impact DaVita Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DVA.

What is DaVita Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, DVA's PE ratio (Price to Earnings) is 15.86 and Price to Sales (PS) ratio is 0.81. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DVA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on DaVita Inc's stock?

In the past 10 years, DaVita Inc has provided 0.054 (multiply by 100 for percentage) rate of return.

Market Summary

DVA Alerts

DVA Stock Price

DVA RSI Chart

DVA Alerts

DVA Valuation

DVA Price/Sales (Trailing)

DVA Profitability

DVA Fundamentals

DVA Revenue

DVA Earnings

Price Action

How does DVA drawdown profile look like?

DVA Financial Health

DVA Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for DVA

Which funds bought or sold DVA recently?

Latest Funds Activity

Schedule 13G FIlings of DaVita Inc

Recent SEC filings of DaVita Inc

DVA Fair Value

Peers (Alternatives to DaVita Inc)

DaVita Inc News

Financials for DaVita Inc

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

DVA Income Statement

DVA Balance Sheet

About DaVita Inc

DaVita Inc Frequently Asked Questions

What is the ticker symbol for DaVita Inc? What does DVA stand for in stocks?

What is the market capital of DaVita Inc (DVA)?

What is the fair value of DVA stock?

Is DaVita Inc a good stock to buy?

What is DaVita Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

What is 5 year return on DaVita Inc's stock?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)